CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 51 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,259,585 | +21.6% | 6,020,000 | -2.9% | 0.26% | +23.9% |
| Q1 2023 | $7,615,069 | +6.9% | 6,198,000 | -1.4% | 0.21% | +14.8% |
| Q4 2022 | $7,123,996 | -1.8% | 6,287,000 | -5.0% | 0.18% | -0.5% |
| Q3 2022 | $7,255,000 | -11.5% | 6,619,000 | -2.4% | 0.18% | -8.0% |
| Q2 2022 | $8,195,000 | -87.5% | 6,783,000 | -82.2% | 0.20% | -65.4% |
| Q1 2022 | $65,472,000 | +3.7% | 38,008,000 | +0.3% | 0.58% | +9.5% |
| Q4 2021 | $63,163,000 | +6.3% | 37,899,000 | -1.1% | 0.52% | -6.2% |
| Q3 2021 | $59,400,000 | -4.0% | 38,329,000 | +0.1% | 0.56% | -3.6% |
| Q2 2021 | $61,845,000 | +11.0% | 38,286,000 | +7.7% | 0.58% | +43.1% |
| Q1 2021 | $55,708,000 | +22.7% | 35,548,000 | +9.8% | 0.41% | +29.7% |
| Q4 2020 | $45,397,000 | +42.2% | 32,384,000 | +14.1% | 0.31% | +44.2% |
| Q3 2020 | $31,930,000 | +8.4% | 28,394,000 | +1.4% | 0.22% | -7.7% |
| Q2 2020 | $29,448,000 | +13.2% | 28,004,000 | +0.2% | 0.24% | -2.5% |
| Q1 2020 | $26,009,000 | – | 27,947,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
| ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
| MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
| Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
| Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
| GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |